Tarsus Pharmaceuticals, Inc. TARS Investment Purchases
Investment Purchases at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s investment purchases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s investment purchases?
- Tarsus Pharmaceuticals, Inc. (TARS) reported investment purchases of $126.8M in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s investment purchases changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s investment purchases increased by 1.0% year-over-year, from $125.57M to $126.8M.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s investment purchases?
- Over 2 years (2022 to 2025), Tarsus Pharmaceuticals, Inc.'s investment purchases has grown at a 62.2% compound annual growth rate (CAGR), from $149.44M to $393.19M.
- What does investment purchases mean?
- Cash spent purchasing investment securities across all categories.